Prevalence of metabolic syndrome and its associated factors in renal transplant recipients.

Introduction: The population of patients undergoing renal transplantation is considered at highrisk for developing obesity and changes in lipid and glucose metabolism, due to the use of immunosuppressive drugs and increased food freedom in the post-transplant period.

Objective: This study was designed to assess the prevalence of metabolic syndrome in renal transplant recipients and to identify factors associated with its occurrence.

Methods: A cross-sectional study was performed in renal transplant patients, with more than six months of follow-up.